메뉴 건너뛰기




Volumn 25, Issue 5, 2001, Pages 309-318

The performance and problems of the Turkish pharmaceutical industry: Is there a need to develop a national drug policy

Author keywords

national drug policy; Turkish pharmaceutical sector

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIANEMIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIMIGRAINE AGENT; ANTIPARASITIC AGENT; ANTIRHEUMATIC AGENT; ANTITUSSIVE AGENT; CARDIOVASCULAR AGENT; DERMATOLOGICAL AGENT; DIURETIC AGENT; HORMONE; HYPNOTIC AGENT; LAXATIVE; MUSCLE RELAXANT AGENT; SPASMOLYTIC AGENT; TRANQUILIZER; VITAMIN; ESSENTIAL DRUG;

EID: 0035486827     PISSN: 01485598     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010685207582     Document Type: Review
Times cited : (9)

References (11)
  • 2
    • 0003734820 scopus 로고    scopus 로고
    • The European Federation of Pharmaceutical Industries and Associations
    • EFPIA, The Pharmaceutical Industry in Figures - 2000 Edition, The European Federation of Pharmaceutical Industries and Associations, 2000.
    • (2000) The Pharmaceutical Industry in Figures - 2000 Edition
  • 3
    • 0027337393 scopus 로고
    • Essential and non-essential drugs marketed by the 20 largest European pharmaceutical companies in developing countries
    • Hartog, R., Essential and non-essential drugs marketed by the 20 largest European pharmaceutical companies in developing countries, Social Sci. Med. 7(7):897-904, 1993.
    • (1993) Social Sci. Med. , vol.7 , Issue.7 , pp. 897-904
    • Hartog, R.1
  • 4
    • 0023949219 scopus 로고
    • Essential drugs for all
    • Hye, H. K. M. A., Essential drugs for all. World Health Forum 9:214-217, 1988.
    • (1988) World Health Forum , vol.9 , pp. 214-217
    • Hye, H.K.M.A.1
  • 5
    • 10244228644 scopus 로고    scopus 로고
    • Tulane University, School of Public Health and Tropical Medicine, Department of International Health and Development, 1996, New Orleans, Louisiana-USA, Unpublished Research
    • Kisa, A., Pharmaceutical Industry in Turkey, Tulane University, School of Public Health and Tropical Medicine, Department of International Health and Development, 1996, New Orleans, Louisiana-USA, Unpublished Research, 1996.
    • (1996) Pharmaceutical Industry in Turkey
    • Kisa, A.1
  • 6
    • 84972629275 scopus 로고
    • National drug formularies: Lessons from Latin America
    • LeRoy, A. A., and Morse, L. M., National drug formularies: Lessons from Latin America. Drug Infor. J. 17:89-94, 1983.
    • (1983) Drug Infor. J. , vol.17 , pp. 89-94
    • LeRoy, A.A.1    Morse, L.M.2
  • 7
    • 0021531079 scopus 로고
    • WHO's Programme on Essential Drugs
    • Lunde, P. K. M., WHO's Programme on Essential Drugs. Danish Med. Bull. 31(1):23-27, 1984.
    • (1984) Danish Med. Bull. , vol.31 , Issue.1 , pp. 23-27
    • Lunde, P.K.M.1
  • 8
    • 10244231585 scopus 로고    scopus 로고
    • Publication of the Pharmaceutical Manufactures' Association
    • Pharmaceutical Manufactures' Association, Pharmaceuticals in Turkey, 1992, 1994, 1995, 1997, 1998, Publication of the Pharmaceutical Manufactures' Association.
    • Pharmaceuticals in Turkey, 1992, 1994, 1995, 1997, 1998
  • 9
    • 0026572871 scopus 로고
    • Why does Australia have no rational drug policy?
    • Smith, A. J., Why does Australia have no rational drug policy? Med. J. Austr. 156:299-300, 1992.
    • (1992) Med. J. Austr. , vol.156 , pp. 299-300
    • Smith, A.J.1
  • 10
    • 0027298391 scopus 로고
    • Essential drugs and registration of pharmaceutical: The Sri Lankan experience
    • Weerasuriya, K., Essential drugs and registration of pharmaceutical: The Sri Lankan experience. Bull. World Health Org. 71(2):229-235, 1993.
    • (1993) Bull. World Health Org. , vol.71 , Issue.2 , pp. 229-235
    • Weerasuriya, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.